Capillary Blood Microsampling in Anti-doping Research

In the arena of athletic competition, curtailing the use of anabolic steroids is one of the most significant challenges. This category includes the performance-enhancing substances that athletes most commonly abuse in the interest of gaining an unfair advantage.

Patient-centric healthcare has taken center-stage. With the increasing access to information, patients want to play a role in treatment methods and applications. Patient-centric sampling has an important part to play.

Many patients come to Dr. Bruno Journe, a specialist in addictology, for help with their problematic consumption of alcohol. Until recently, “there was no criterion to distinguish between a subjective and an objective relation to the misuse of alcohol,” says Dr. Journe. “Even a biological test such as MCG, ASAT, ALAT, GGT, or CDT lacks sensitivity and can lead to the wrong diagnosis.”

This is changing now thanks to advancing methods of measuring phosphatidylethanol, or PEth, a biomarker produced in cell membranes that correlates with recent alcohol use in a way that is highly specific. “PEth brings unique information that was never available before,” Dr. Journe says. “Denial is no longer possible.”

In 2020, the capabilities of remote patient monitoring technology will be more powerful, effective, and interesting than ever before.

According to IHS (Information Handling Services), more than four million patients will monitor their health conditions remotely by 2020. This is a 34% increase in remote patient monitoring (RPM), thanks to many innovation advancements since 2014.

At Neoteryx, we work with top scientists and researchers to help facilitate and promote their revolutionary work using Mitra^® microsampling devices and Volumetric Absorptive Microsampling (VAMS^®) technology.

New work using microsampling in proteomics has transformative implications for science and research, for patient outcomes, and for the way labs do business.

"Having spent years attempting to discover new protein biomarkers, the most interesting and highly motivating thing about our proteomics work is how we might now be able to bring it to the stage where it has impact by improving patient outcomes," says Dr. Stephen Pennington of University College Dublin, whose work in proteomics using Mitra^® microsampling devices has indeed begun to garner wider attention.